Medtronic’s cardiac and vascular group president, Michael Coyle, questions CardioMEMS’ implantable heart monitor, citing Medtronic’s experience with its now-abandoned Chronicle monitor. The Champion implantable heart monitor made by CardioMEMS might not prove as cost-effective as a non-invasive approach, at least according to Medtronic (NYSE:MDT) cardiac and vascular group president Michael Coyle. Coyle, speaking at the 25th Annual Piper Jaffray Healthcare Conference yesterday, cited Medtronic’s negative experience with its Chronicle implantable cardiac monitor.
Help employers find you! Check out all the jobs and post your resume.
